- Supported exchanges /
- F /
- 5J2.F
GABATHER AB (PUBL) SK-44 (5J2 F) stock market data APIs
Gabather AB (publ), a pharmaceutical company, researches and develops drug candidates for the treatment of central nervous system diseases. It offers drugs primarily in the areas of anti-psychotics; anti-depressants and anxiolytics; analgesics; and cognition-enhancing treatments, including Alzheimer's disease. The company develops GT-002 for the treatment of schizophrenia, major depressive disorder, orphan drug, and alzheimer´s disease. It has a collaborative agreement with the Centre for Neuropsychiatric Schizophrenia Research at the Psychiatric Centre in Glostrup to conduct a so-called clinical phase II study with GT-002 in patients diagnosed with schizophrenia. Gabather AB (publ) was incorporated in 2014 and is based in Södertälje Sweden.
GABATHER AB (PUBL) SK-44 Financial Data Overview
| 0.038 | |
| 0.038 | |
| - | |
| 0.038 | |
| 0.038 | |
| 0.0134-0.237 | |
| 1 146 K | |
| 23 718 K | |
| 0 | |
| 0.269 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
GABATHER AB (PUBL) SK-44 Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA 0
- Earnings Per Share -0.06
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get GABATHER AB (PUBL) SK-44 Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get GABATHER AB (PUBL) SK-44 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
